Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids

European Journal of Medicinal Chemistry
2007.0

Abstract

With an intention to synergise the antibacterial activity of chalcones and oxazolidinones, several hybrid compounds possessing both chalcone and oxazolidinone moieties were synthesized and tested for antibacterial activity. The hybrid molecules containing heterocycles instead of aromatic ring were found to be active. A SAR study with various heterocycles resulted in a lead molecule 20, which was converted to one of the potent antibacterial compounds 27.

Knowledge Graph

Similar Paper

Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids
European Journal of Medicinal Chemistry 2007.0
Novel Chalcone–Thiazole Hybrids as Potent Inhibitors of Drug ResistantStaphylococcus aureus
ACS Medicinal Chemistry Letters 2015.0
Synthesis and crystal structure of chalcones as well as on cytotoxicity and antibacterial properties
Medicinal Chemistry Research 2012.0
Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity
European Journal of Medicinal Chemistry 2010.0
Synthesis and antibacterial activities of novel oxazolidinones having cyclic sulfonamide moieties
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents
European Journal of Medicinal Chemistry 2011.0
Synthesis, antibacterial evaluation and QSAR studies of 7-[4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl] quinolone derivatives
European Journal of Medicinal Chemistry 2011.0
Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus
Bioorganic & Medicinal Chemistry Letters 2012.0